{
    "paper_id": "20154fa12ca525582cd1b42019927e8f7816fb51",
    "metadata": {
        "title": "Validation and automation of a high-throughput multi-targeted method for semi-quantification of 2 endogenous metabolites from different biological matrices using tandem mass spectrometry 4",
        "authors": [
            {
                "first": "Jatin",
                "middle": [],
                "last": "Nandania",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "HiLIFE",
                    "location": {
                        "addrLine": "6 Tukholmankatu 8, Biomedicum 2U",
                        "postCode": "00290",
                        "settlement": "Helsinki",
                        "country": "Finland"
                    }
                },
                "email": ""
            },
            {
                "first": "Peddinti",
                "middle": [],
                "last": "Gopal",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Alberto",
                "middle": [],
                "last": "2#",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Helsinki",
                    "location": {
                        "postCode": "00290",
                        "settlement": "Helsinki",
                        "country": "Finland"
                    }
                },
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Pessia",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "HiLIFE",
                    "location": {
                        "addrLine": "6 Tukholmankatu 8, Biomedicum 2U",
                        "postCode": "00290",
                        "settlement": "Helsinki",
                        "country": "Finland"
                    }
                },
                "email": ""
            },
            {
                "first": "Meri",
                "middle": [],
                "last": "Kokkonen",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "HiLIFE",
                    "location": {
                        "addrLine": "6 Tukholmankatu 8, Biomedicum 2U",
                        "postCode": "00290",
                        "settlement": "Helsinki",
                        "country": "Finland"
                    }
                },
                "email": ""
            },
            {
                "first": "\u00a7",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Vidya",
                "middle": [],
                "last": "Velagapudi",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "HiLIFE",
                    "location": {
                        "addrLine": "6 Tukholmankatu 8, Biomedicum 2U",
                        "postCode": "00290",
                        "settlement": "Helsinki",
                        "country": "Finland"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "The use of metabolomics profiling to understand metabolism under different 20 physiological states has increased in recent years, which created the need for robust analytical 21 platforms. Here, we present a validated method for targeted and semi-quantitative analysis of 102 22 polar metabolites that covers major metabolic pathways from 24 classes in a single 17.5-min assay.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "The method has been optimized for a wide range of biological matrices from various organisms, 24 and involves automated sample preparation, and data processing using in-house developed R 25 package. To ensure reliability, the method was validated for accuracy, precision, selectivity, 26 specificity, linearity, recovery, and stability according to European Medicines Agency guidelines.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "We demonstrated excellent repeatability of the retention times (CV<4%), calibration curves 28 (R 2 \u22650.980) in their respective wide dynamic concentration ranges (CV<3%), and concentrations 29 (CV<25%) of quality control samples interspersed within 25 batches analyzed over a period of one-",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "year. The robustness was demonstrated through high correlation between metabolite 31 concentrations measured using our method and NIST reference values (R 2 =0.967), including cross-32 platform comparability against the BIOCRATES AbsoluteIDQp180 kit (R 2 =0.975) and NMR analyses 33 (R 2 =0.884). We have shown that our method can be successfully applied in many biomedical 34 research fields and clinical trials, including epidemiological studies for biomarker discovery. In 35 summary, a thorough validation demonstrated that our method is reproducible, robust, reliable, 36 and suitable for metabolomics studies.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "after addition of an internal standards working solution, biofluid samples were extracted with 1% 96 formic acid in 99% acetonitrile. Tissue samples were extracted using homogenization in two steps.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "of 27"
        },
        {
            "text": "Extraction was first performed with 1% formic acid in 99% acetonitrile; the second extraction used 98 80/20% ACN/H2O+1% formic acid by protein precipitation followed by filtration through Ostro 99 plates. After this step, 5 \u03bcL of filtered sample extract was injected into an Acquity UPLC system 117 metabolites in a single method. However, they did not use an automated platform and a drying step 118 in their method increases the analysis time of the method overall. Our method has clear advantages 119 compared to other published methods, including shorter analysis time, high throughput, automation, 120 and semi-quantitation using individual external 11-point calibration curves along with 12 labeled 121 internal standards. Furthermore, the method has been used in many biomedical and clinical studies 122 for biomarker discovery [10, 11, .",
            "cite_spans": [
                {
                    "start": 835,
                    "end": 839,
                    "text": "[10,",
                    "ref_id": null
                },
                {
                    "start": 840,
                    "end": 843,
                    "text": "11,",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "97"
        },
        {
            "text": "The primary objective of this work is to show the robustness of our method through a thorough 124 validation of our previously developed analytical method according to European Medicines Agency 125 (EMA) guidelines. We also demonstrate automation of tedious and manual data processing tasks in 126 high-throughput metabolomics analyses using an in-house developed R package. The R package 127 automates various corrections and normalization steps to convert the raw peak area data to molecular 128 concentrations for each compound in each sample and also provides quality evaluation of the data 129 and reduces the manual work load significantly. International (Helsinki, Finland). Analytical-grade chemicals (formic acid, ammonium formate, and 137 ammonium hydroxide) were obtained from Sigma-Aldrich. Deionized water (18 M\u2126.cm at 25\u00b0C) 138 used for solution preparation was made using a Milli-Q water purification system (Bamstead",
            "cite_spans": [
                {
                    "start": 819,
                    "end": 837,
                    "text": "(18 M\u2126.cm at 25\u00b0C)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "123"
        },
        {
            "text": "EASYpure RoDi ultrapure water purification system, Thermo scientific, Ohio, USA). Mouse tissues, 140 including heart, liver, brain, spleen, and muscles were obtained from Innovative Research Laboratory 141 (Novi, MI, USA). Whole blood was obtained from the Finnish Red Cross blood service (Helsinki, 142 Finland), from which serum was prepared during method optimization and validation. Cell samples 143 author/funder. All rights reserved. No reuse allowed without permission. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "139"
        },
        {
            "text": "After optimization, we used the tissues protocol for analysis of various biological matrices, such as 155 heart, liver, placenta, brain, muscles, spleen, C. elegans, Drosophila larvae, dental carries, dried blood 156 spots, and fecal samples. To assess the linearity, accuracy, and precision, six replicates of spiked QC samples at high, 182 medium, and low concentrations along with calibration curve were injected on three separate days.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "154"
        },
        {
            "text": "Calibration curve standards of 11 points were prepared via serial dilution. The curve was plotted by 184 using the peak area response ratios (standard/labeled standard) versus the concentrations of the 185 individual metabolites. The calibration curve was constructed using the regression equations (linear 186 and quadratic) by applying appropriate weighing factor and by transforming the axis (both 187 instrument response and theoretical concentration) into logarithmic or square root function. The 188 author/funder. All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "183"
        },
        {
            "text": "The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/352468 doi: bioRxiv preprint ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "183"
        },
        {
            "text": "author/funder. All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "234"
        },
        {
            "text": "The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/352468 doi: bioRxiv preprint ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "234"
        },
        {
            "text": "(ii) Process efficiency correction for the semi-quantification of metabolites without internal 266 standards.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "265"
        },
        {
            "text": "(iii) Normalization using dilution factor for specific sample type if dilution was needed.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "267"
        },
        {
            "text": "(iv) Cell number normalization (for cell samples) to convert the concentration values per million 269 cells.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "268"
        },
        {
            "text": "(v) Calculation of mean, standard deviation, and relative standard deviation (RSD) of molecular 271 concentrations (resulting from the previous steps) for each phenotypic group.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "270"
        },
        {
            "text": "(vi) Outlier detection in each phenotypic group; if the concentration value of a compound in a 273 sample is more than one or two standard deviation (SD) away from the mean of the 274 phenotypic group, then it is marked as an outlier in the Excel data set in two different colors. The primary objective of this work was to optimize and validate our previously published 283 protocol for different types of biological matrices. For tissue samples (placenta, liver, heart, brain, 284 spleen, and muscles), the sample volumes of the tissues and extraction solvent volumes were 285 optimized to fit the concentrations of most of the metabolites within the linearity of calibration curve 286 for reliable results. We observed that most of the metabolites can be semi-quantified within the 287 calibration curve range with 20\u00b15mg of sample weight.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "272"
        },
        {
            "text": "Furthermore, we optimized the protocol with extraction solvent for tissues and adherent cells.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "288"
        },
        {
            "text": "Some of the metabolites (in particular inositol, GABA, asymmetric dimethylarginine, symmetric 290 dimethylarginine, spermidine, ribose-5-phosphate, and orotic acid) had poor separation and 291 irreproducible chromatography. Interference of isobaric compounds with other metabolites was also 292 observed due to poor separation. Thus, different compositions of the extraction solvent were assessed 293 to achieve the acceptable chromatography. We observed that modification of acetonitrile content 294 from 80% to 90% and applying longer equilibration time for the HILIC column yielded acceptable 295 chromatography and also good separation for most of the metabolites.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "289"
        },
        {
            "text": "We also optimized the extraction protocol for different sample types from various organisms, 297 such as tissue types (adipose, endometrium, testicles, lung), fecal samples, dried blood samples, To cover a broad concentration range, the linear or quadratic models were used and the variables 319 from X and Y axes were logarithm or squareroot transformed to fit the calibration data [43] . The 320 coefficient of determination (R 2 ) value for each metabolite was greater than 0.980 at their respective 321 concentration range, except for some metabolites such as aspartate, uracil, 2-deoxyuridine sucrose, 322 and chenodeoxycholic acid (likely due to their broad peak shapes and poor recovery at lower 323 concentration, Table S1 ).",
            "cite_spans": [
                {
                    "start": 383,
                    "end": 387,
                    "text": "[43]",
                    "ref_id": null
                }
            ],
            "ref_spans": [
                {
                    "start": 722,
                    "end": 730,
                    "text": "Table S1",
                    "ref_id": "TABREF5"
                }
            ],
            "section": "296"
        },
        {
            "text": "Concentration precision for QC samples was calculated by measuring %CV at high, medium, 325 and low concentration level of QCs (N=6 replicates). In general, intra-and inter-day precision (CV) 326 values were within 15% for most of the metabolites except acetoacetic acid, folic acid, sucrose, 327 homoserine, 2-deoxyuridine, and cholic acid ( Figure 3) . However, at low concentrations, more than 328 20% CV were observed for NAD and myo-inositol. This might be due to the low recoveries of these 329 compounds.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 343,
                    "end": 352,
                    "text": "Figure 3)",
                    "ref_id": "FIGREF23"
                }
            ],
            "section": "324"
        },
        {
            "text": "author/funder. All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "331"
        },
        {
            "text": "The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/352468 doi: bioRxiv preprint For most of the metabolites, recoveries were found to be between 50% to 120% with good 335 repeatability at all three concentrations levels (low, medium, and high) in both biofluid (serum) and 336 tissues (brain, liver, and spleen). However, compounds such as UDP-glucose, IMP, cGMP, D-ribose 337 5-phosphate, NAD, AMP, homocysteine, carnosine, and glutathione had recoveries less than 30% in 338 serum. However, CV of recoveries at low, medium, and high concentration levels were within 25% 339 except for cGMP in serum. Metabolites such as 1-methylhistamine, aspartate, glutamine, adenosine, 340 and glutathione had recoveries over 120%. Histidine, ornithine, cystathionine, 3-OH-DL-kynurenine, 341 carnosine, AMP, NAD, cGMP, IMP, and UDP-glucose had less than 30% recovery in some tissues 342 types, indicating matrix effect or degradation (Figure 4) . However, CV of repeatability at all 343 concentration levels were within 15% except for 1-methylhistamine, aspartate, glutamine, 344 glutathione, NAD, and UDP-glucose in some tissues.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 974,
                    "end": 984,
                    "text": "(Figure 4)",
                    "ref_id": "FIGREF25"
                }
            ],
            "section": "331"
        },
        {
            "text": "The matrix effect values were observed to be within the range of 0.6 to 1.8 (below 1 indicates ion 346 suppression and above 1 indicates ion enhancement) for the metabolites in serum and tissues. The 347 challenge of the matrix effect can be overcome by having individual isotope-labeled internal 348 standards for each individual compound for true quantification. However, this is not practically 349 possible for high-throughput metabolomics analyses, where usually the aim is relative comparison 350 of cases vs controls. This is due to high costs and also because not all internal standards are 351 author/funder. All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "345"
        },
        {
            "text": "The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/352468 doi: bioRxiv preprint 10 of 27 commercially available. In our method, we selected 12 labeled internal standards (Table S1 ), which 352 represent chemically similar classes for optimal correction. This is because the matrix effect was 353 expected to be the same for an analyte and its labeled isotope analogue. The process efficiency 354 percentages were calculated for the metabolites without internal standards. The analyte 355 concentrations determined through the external calibration were divided with the total process 356 efficiency values to correct the concentration values of the analyte in the given biological sample.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 221,
                    "end": 230,
                    "text": "(Table S1",
                    "ref_id": "TABREF5"
                }
            ],
            "section": "345"
        },
        {
            "text": "Also, the repeatability of matrix effect in terms of CV was less than 25% for most of the compounds.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "357"
        },
        {
            "text": "Reliable measurements are accordingly possible. 359 author/funder. All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "358"
        },
        {
            "text": "The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/352468 doi: bioRxiv preprint ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "358"
        },
        {
            "text": "approximately 90% of the metabolites were stable (stabilities range between 85% and 115%) for 35 368 hours at 5 o C in the auto-sampler ( Figure 5A ).",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 138,
                    "end": 147,
                    "text": "Figure 5A",
                    "ref_id": "FIGREF29"
                }
            ],
            "section": "367"
        },
        {
            "text": "For freeze and thaw cycle stability, most of the metabolites were stable even after three freeze 370 and thaw cycles, with the exception of cGMP, succinate, glutathione, and homocysteine (stability 371 below 30%, Figure 5B ). This information is particularly important for clinical studies, where samples 372 are often thawed once or twice.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 213,
                    "end": 222,
                    "text": "Figure 5B",
                    "ref_id": "FIGREF29"
                }
            ],
            "section": "369"
        },
        {
            "text": "To determine the stability of working solutions, we started evaluating the stability from The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/352468 doi: bioRxiv preprint The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/352468 doi: bioRxiv preprint In general, for majority of the analyte MRM channels neither peak nor any interference in the 388 blank samples was detected after injection of metabolite standard with high concentration. For 389 compounds such as spermidine, succinate, AMP, and IMP, carryover eluted constantly even after 390 washing but was not significantly high. Other than these compounds, we can conclude that the 391 column, needle, syringe, and seal washes were sufficient to avoid any inter-sample carryover. The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/352468 doi: bioRxiv preprint",
            "cite_spans": [],
            "ref_spans": [],
            "section": "373"
        },
        {
            "text": "To obtain reproducible and accurate data, we set up a strict quality management and electronic 418 lab notebook system. To reduce the bias from sample analysis, we always double-randomized the 419 samples (i.e., one before the sample extraction step and one before injecting into the LCMS system 420 across different phenotypes of the samples). For stabilization of response and retention time, we 421 always verified a few runs of highest calibration level 11 before injecting the experimental samples.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "417"
        },
        {
            "text": "During the stabilization process, we also verified the chromatography including peak shape, 423 retention time, and response of all the metabolites. Any significant changes in the intensity, peak 424 shape, retention time, and system pressure were thoroughly investigated and corrected by resolving 425 the problems before injection of experimental samples.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "422"
        },
        {
            "text": "To ensure the integrity of LCMS runs, QC samples were run at every tenth experimental sample 427 and a blank sample at every fifth run during all the metabolomics studies within a batch.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "426"
        },
        {
            "text": "Furthermore, chromatography and response of QC samples (including chromatography of some 429 metabolites and IS response variation) and blank runs were always verified after completion of the 430 runs and before starting data processing. In case of any abnormality observed for particular samples, 431 those samples were reinjected or reanalyzed. Only after passing these quality checks we proceed 432 further to process the data. This included verifying the accuracy of calibration curve standards, 445 author/funder. All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "428"
        },
        {
            "text": "The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/352468 doi: bioRxiv preprint Figure 10A ).",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 131,
                    "end": 141,
                    "text": "Figure 10A",
                    "ref_id": "FIGREF37"
                }
            ],
            "section": "428"
        },
        {
            "text": "Furthermore, we verified cross-platform comparability. This was achieved by comparing ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "451"
        },
        {
            "text": "Error bars represent 95% confidence intervals. weight or cell number depending on the sample type. Apart from these steps, as the samples are 478 analyzed in a randomized manner, the next step is to rearrange the experimental samples according 479 to phenotypic group and also to separate the QC samples. Manual data formatting to create a ready-480 author/funder. All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "467"
        },
        {
            "text": "The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/352468 doi: bioRxiv preprint 23 of 27 to-use data matrix for visualization and for downstream statistical analyses is a tedious and time-481 consuming task and (most importantly) is prone to errors.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "467"
        },
        {
            "text": "We have implemented a software package \"Unlynx\" in R statistical language. This package takes 483 the raw data produced by TargetLynx software as input and produces processed data into ready-to-484 use spreadsheets. Using the R package, all the PPB values are converted into \u00b5mol/L, \u00b5mol/g, or 485 \u00b5mol/million cells by diving with molecular weight of the respective metabolites and correction 486 factor (weight of tissues, number of cells, and dilution factor) with respect to sample types. In ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "482"
        },
        {
            "text": "Thus, after processing the data using TargetLynx, we routinely export all results to an excel file 494 for automated data processing using \"Unlynx\" software. Typically, the data resulting from such 495 automated data processing is suitable for more specialized data analyses ( ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "493"
        },
        {
            "text": "The developed high-throughput targeted and semi-quantitative method was optimized for various 509 biological matrices (biofluids, tissues, cells) from different organisms. We validated the analytical 510 method according to EMA guidelines for bioanalytical methods and showed good accuracy, 511 reproducibility, selectivity, specificity, recoveries, and stability. We have also implemented a strict 512 quality management and electronic notebook system. Reproducibility was demonstrated by 513 consistent results for retention time and correlation coefficient of calibration curves, and 514 concentrations of QC samples over a period of 1 year. Reliability was shown by the excellent 515 correlation between metabolite concentrations measured using our method and the NIST reference 516 values. Moreover, robustness was shown via good cross-platform comparability between two 517 completely different analytical platforms. Furthermore, we have automated the downstream data 518 processing steps to handle sample analyses in a high-throughput manner, which is particularly 519 valuable for analyzing population cohorts and large clinical samples for metabolomics studies. We 520 have successfully applied this method in many biomedical research projects and clinical trials, 521 including epidemiological studies for biomarker discovery.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "508"
        },
        {
            "text": "Supplementary Materials: The following are available online at www.mdpi.com/link, The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/352468 doi: bioRxiv preprint",
            "cite_spans": [],
            "ref_spans": [],
            "section": "523"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Overview of mass spectrometry-based metabolomics: Opportunities and 541 challenges",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "A N"
                    ],
                    "last": "Gowda",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Djukovic",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Methods Mol Biol",
            "volume": "1198",
            "issn": "",
            "pages": "3--12",
            "other_ids": {
                "DOI": [
                    "10.1007/978-1-4939-1258-2_1"
                ]
            }
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Targeted metabolomics and mass spectrometry",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Dudley",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Yousef",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "J"
                    ],
                    "last": "Griffiths",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Adv",
            "volume": "543",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Recent developments in 545 sample-pretreatment techniques for mass spectrometry-based metabolomics. TrAC Trends in Analytical 546 Chemistry",
            "authors": [
                {
                    "first": "R.-J",
                    "middle": [],
                    "last": "Raterink",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "W"
                    ],
                    "last": "Lindenburg",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "J"
                    ],
                    "last": "Vreeken",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Ramautar",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Hankemeier",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "Y.-J",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "",
            "volume": "61",
            "issn": "",
            "pages": "157--167",
            "other_ids": {
                "DOI": [
                    "10.1016/j.trac.2014.06.003"
                ]
            }
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "A robust, single-injection method for 571 targeted, broad-spectrum plasma metabolomics",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Naviaux",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "T"
                    ],
                    "last": "Bright",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "K"
                    ],
                    "last": "Naviaux",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "",
            "volume": "13",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1007/s11306-017-572"
                ]
            }
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Determination of thiol metabolites in human urine 574 by stable isotope labeling in combination with pseudo-targeted mass spectrometry analysis",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "C.-B",
                    "middle": [],
                    "last": "Qi",
                    "suffix": ""
                },
                {
                    "first": "Q.-F",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "B.-F",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                },
                {
                    "first": "Y.-Q",
                    "middle": [],
                    "last": "Feng",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Scientific 575 Reports",
            "volume": "6",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1038/srep21433"
                ]
            }
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Targeted full-scan lc-ms metabolomics: Simultaneous quantitation of knowns and 577 feature discovery provide the best of both worlds",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "P"
                    ],
                    "last": "Rosebrock",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Bioanalysis",
            "volume": "9",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.4155/bio-2016-0256"
                ]
            }
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "High-throughput and multiplexed lc/ms/mrm method for targeted 579 metabolomics",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "B"
                    ],
                    "last": "Seymour",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Anal Chem",
            "volume": "82",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1021/ac100331b"
                ]
            }
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "A positive/negative ion-switching, targeted mass 581 spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "B"
                    ],
                    "last": "Breitkopf",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Asara",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Nat",
            "volume": "582",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Mitochondrial DNA Replication Defects Disturb 587 Cellular dNTP Pools And Remodel One-Carbon Metabolism",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Velagapudi",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Carroll",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Suomalainen",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Cell Metab",
            "volume": "23",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.cmet.2016.01.019"
                ]
            }
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Modified Atkins diet 591 induces subacute selective ragged red fiber lysis in mitochondrial myopathy patients",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Hakkarainen",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Muurinen",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Piiril\u00e4",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Pietil\u00e4inen",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Suomalainen",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "EMBO Mol Med",
            "volume": "592",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.15252/emmm.201606592"
                ]
            }
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Effect of 594 high-carbohydrate diet on plasma metabolomics in mice with mitochondrial respiratory chain complex 595 III deficiency due to a Bcs1l mutation",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Rajendran",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Toma\u0161i\u0107",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Kotarsky",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Hansson",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Velagapudi",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kallij\u00e4rvi",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Fellman",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Int J Mol Sci",
            "volume": "17",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.3390/ijms17111824"
                ]
            }
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Broad AOX expression in a genetically tractable mouse model does not disturb normal physiology",
            "authors": [],
            "year": null,
            "venue": "Dis",
            "volume": "600",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "CLUH regulates 603 mitochondrial metabolism by controlling translation and decay of target mRNAs",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Corona",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Kondylis",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Barth",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Schauss",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Velagapudi",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Rugarli",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "J Cell Biol",
            "volume": "216",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1083/jcb.201607019"
                ]
            }
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Ketogenic diet attenuates 607 hepatopathy in mouse model of respiratory chain complex III deficiency caused by a Bcs1l mutation",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Velagapudi",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Kere",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Jauhiainen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Fellman",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Kallij\u00e4rvi",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Suomalainen",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Cell Metab",
            "volume": "26",
            "issn": "",
            "pages": "419--428",
            "other_ids": {
                "DOI": [
                    "10.1101/352468"
                ]
            }
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Host-Microbe Co-metabolism Dictates Cancer Drug Efficacy in C.elegans",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "D E"
                    ],
                    "last": "Cabreiro",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "",
            "volume": "615",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.cell.2017.03.040"
                ]
            }
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Metabolomic profiling of extracellular vesicles and alternative normalisation methodsreveal enriched 619 metabolites and strategies to study prostate cancer related changes",
            "authors": [],
            "year": 2017,
            "venue": "",
            "volume": "7",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.7150/thno.19890"
                ]
            }
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "GATA4 is a key regulator of 623 steroidogenesis and glycolysis in mouse Leydig cells",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Velagapudi",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Toppari",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wilson",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "B"
                    ],
                    "last": "Heikinheimo",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Endocrinology",
            "volume": "156",
            "issn": "",
            "pages": "1860--1872",
            "other_ids": {
                "DOI": [
                    "10.1210/en.2014-1931"
                ]
            }
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "GATA4 regulates blood-testis barrier function and lactate 627 metabolism in mouse Sertoli cells",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Toppari",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wilson",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "B"
                    ],
                    "last": "Heikinheimo",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Endocrinology",
            "volume": "157",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1210/en.2015-1927"
                ]
            }
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Purine metabolism is dysregulated in 630 patients with major depressive disorder",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Honkalampi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ruusunen",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Velagapudi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Lehto",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Psychoneuroendocrinology",
            "volume": "70",
            "issn": "",
            "pages": "25--32",
            "other_ids": {
                "DOI": [
                    "10.1016/j.psyneuen.2016.04.017"
                ]
            }
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Fecal and serum metabolomics in 633 pediatric inflammatory bowel disease",
            "authors": [
                {
                    "first": "K.-L",
                    "middle": [],
                    "last": "Kolho",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Pessia",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Jaakkola",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "M"
                    ],
                    "last": "De Vos",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Velagapudi",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "J Crohns Colitis",
            "volume": "11",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1093/ecco-jcc/jjw158"
                ]
            }
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "NJ872 inhibits influenza A virus replication without altering cellular 636 antiviral responses",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Velagapudi",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Kainov",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "E"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Antiviral Res",
            "volume": "133",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.antiviral.2016.07.008"
                ]
            }
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "Regulation of Kynurenine Biosynthesis during Influenza Virus Infection",
            "authors": [],
            "year": 2017,
            "venue": "FEBS J",
            "volume": "284",
            "issn": "",
            "pages": "222--236",
            "other_ids": {
                "DOI": [
                    "10.1111/febs.13966"
                ]
            }
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro 644 and differentially affect cellular signaling, transcription and metabolism",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "E"
                    ],
                    "last": "Vapalahti",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Obatoclax",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Antiviral Res",
            "volume": "139",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.antiviral.2016.12.022"
                ]
            }
        },
        "BIBREF56": {
            "ref_id": "b56",
            "title": "Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins",
            "authors": [],
            "year": 2017,
            "venue": "",
            "volume": "9",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.3390/v9100271"
                ]
            }
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (which was not peer-reviewed) is the",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/352468"
                ]
            }
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "Activation of Tryptophan and Phenylalanine Catabolism in the Remission Phase of 656",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Velagapudi",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF60": {
            "ref_id": "b60",
            "title": "Allergic Contact Dermatitis: A Pilot Study",
            "authors": [],
            "year": 2016,
            "venue": "Int Arch Allergy Immunol",
            "volume": "170",
            "issn": "",
            "pages": "262--268",
            "other_ids": {
                "DOI": [
                    "10.1159/000450789"
                ]
            }
        },
        "BIBREF63": {
            "ref_id": "b63",
            "title": "Combined immunodeficiency with hypoglycemia caused by mutations in hypoxia up-661 regulated 1",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kere",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "J Allergy Clin Immunol",
            "volume": "139",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jaci.2016.09.050"
                ]
            }
        },
        "BIBREF65": {
            "ref_id": "b65",
            "title": "The Pentose Phosphate Pathway Regulates the Circadian 664",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Velagapudi",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "O&apos;neill",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Reddy",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "B"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF68": {
            "ref_id": "b68",
            "title": "The association between musculoskeletal pain and circulating ornithine: A population-667 based study",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Lehto",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "European Medicines Agency",
            "volume": "18",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1093/pm/pnw285.66838"
                ]
            }
        },
        "BIBREF71": {
            "ref_id": "b71",
            "title": "Metabolite Profiling of a NIST Standard Reference Material for 672",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "P"
                    ],
                    "last": "Karen",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "R"
                    ],
                    "last": "Alan",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "S"
                    ],
                    "last": "Stephen",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF72": {
            "ref_id": "b72",
            "title": "SRM 1950): GC/MS, LC/MS, NMR and Clinical Laboratory Analyses",
            "authors": [
                {
                    "first": "Human",
                    "middle": [],
                    "last": "Plasma",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF73": {
            "ref_id": "b73",
            "title": "Web-based resources",
            "authors": [],
            "year": 2013,
            "venue": "Anal Chem",
            "volume": "674",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1021/ac402503m"
                ]
            }
        },
        "BIBREF76": {
            "ref_id": "b76",
            "title": "Interlaboratory Reproducibility of a Targeted Metabolomics Platform for Analysis of Human Serum 677 and Plasma",
            "authors": [],
            "year": 2017,
            "venue": "",
            "volume": "89",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1021/acs.analchem.6b02930"
                ]
            }
        },
        "BIBREF77": {
            "ref_id": "b77",
            "title": "Automated 679 quantum mechanical total line shape fitting model for quantitative NMR-based profiling of human 680 serum metabolites",
            "authors": [
                {
                    "first": "V",
                    "middle": [
                        "V"
                    ],
                    "last": "Mihaleva",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "P"
                    ],
                    "last": "Korhonen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Van Duynhoven",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Niemitz",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Vervoort",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "M"
                    ],
                    "last": "Jacobs",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Anal Bioanal Chem",
            "volume": "406",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1007/s00216-014-7752-5"
                ]
            }
        },
        "BIBREF78": {
            "ref_id": "b78",
            "title": "Mcmc methods for multi-response generalized linear mixed models: The mcmcglmm r 682 package",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "D"
                    ],
                    "last": "Hadfield",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Jouranl of statistical software 2010",
            "volume": "33",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.18637/jss.v033.i02"
                ]
            }
        },
        "BIBREF79": {
            "ref_id": "b79",
            "title": "Bioanalytical calibration curves: proposal for statistical criteria",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "K"
                    ],
                    "last": "Kimanani",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "J. Pharm. Biomed. Anal",
            "volume": "684",
            "issn": "",
            "pages": "1117--1124",
            "other_ids": {
                "DOI": [
                    "10.1016/S0731-7085(97)00064-2"
                ]
            }
        },
        "BIBREF80": {
            "ref_id": "b80",
            "title": "\u00a9 2017 by the authors. Submitted for possible open access publication under the 687 terms and conditions of the Creative Commons Attribution (CC BY) license 688",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF81": {
            "ref_id": "b81",
            "title": "No reuse allowed without permission. The copyright holder for this preprint (which was not peer-reviewed) is the",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/352468"
                ]
            }
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "100 coupled to a Xevo\u00ae TQ-S triple quadrupole mass spectrometer (Waters Corporation, Milford, MA, 101 USA), which was operated in both positive and negative polarities with a polarity switching time of 102 20 msec for metabolite separation and quantification. Multiple Reaction Monitoring (MRM) 103 acquisition mode was selected for metabolite quantification. A detailed method description and 104 instrument parameters are provided elsewhere [10,11]. Our method involves automated sample 105 preparation for biofluid samples and minimal manual steps for non-biofluid samples. This reduces 106 the analysis time and inter-batch variation and minimizes human error. Semi-quantification of the 107 metabolites was performed using external calibration curves (R 2 \u22650.980) in their respective wide 108 dynamic concentration ranges and 12 labeled internal standards were used for most of the 109 metabolites to minimize matrix effects.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Several analytical methods have also been developed for semi-quantitative measurement of 111 large number of metabolites in a single run [12-16]. Li et al [12] measured 610 metabolites from 60 112 biochemical pathways. However, their method requires approximately 40 minutes to separate all the 113 metabolites (with poor resolution for some metabolites). Furthermore, their method was not 114 applicable to all biological matrices. Similarly, Wei et al [15] detected approximately 200 metabolites 115 in 10 minutes from plasma. However, their method lacks information on validation and for other 116 biological matrices. Yuan et al [16] also provided a protocol for detection of approximately 250",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "metabolite standards were purchased from Sigma-Aldrich (St. Louis, MO, USA). Internal 134 standards were ordered from Cambridge Isotope Laboratory. Inc. (Tewksbury, MA, USA). LC-MS-135 grade solvents, 2-proponol, acetonitrile, and methanol (HiPerSolv) were obtained from VWR",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "167medium and low (for serum) or high and low concentration levels (for tissues) were prepared by 168 spiking a mixed standard solution in their respective homogenized biological matrices to perform all 169 the method validation experiments. We performed validation for commonly used biological samples 170 in metabolomics analyses, such as biofluid (serum), tissue (liver, brain and spleen), and cell samples.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "171An aqueous calibration curve was used to calculate the concentration values during the method 172 validation. The instrument performance for response reproducibility and sensitivity was always 173 verified by six consecutive injections of medium concentration solution at the start of any experiment.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": "and specificity for each metabolite were investigated using serum-spiked samples 176 (N=6) with known amount of standard. Chromatographic interferences from other endogenous 177 compounds of the biological matrix at the retention time of the target analyte for a particular 178 metabolite were verified. The chromatographic peaks from spiked samples were compared with the 179 standards by the retention times and if required from their respective MRM spectra.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF8": {
            "text": "calculated as measured value divided by the nominal value at each concentration level 189 of the calibration curve standards in all three batches. Inter-and intra-batch variability was calculated 190 by measuring coefficient of variation (%CV) at each QC concentration level.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF9": {
            "text": "efficiencies for each analyzed metabolite was determined by comparing analytical 193 results from QC samples spiked with standards mixture before and after extraction using different 194 concentrations. The spike concentrations covered the calibration range. The matrix effect (percentage 195 of ion suppression or enhancement of the MS signal) was determined by comparing the analytical 196 response of QC samples that were spiked after extraction with the analytical response of aqueous 197 spiked samples (diluent spiked with respective concentrations of QCs). Since there were endogenous 198 metabolites, we subtracted the endogenous concentrations from the samples that were spiked. This 199 experiment was performed using six QC replicates.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF10": {
            "text": "extract, freeze-thaw, and stock solution stability for all metabolites were determined to 202 check the integrity of the analytes in solvents and in QC samples at different conditions. To determine 203 the wet extract stability, six replicates of extracted QC samples were kept in the auto-sampler at 5\u00b0C.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF11": {
            "text": "The same samples in the same sequence were reinjected with freshly extracted QC samples and the 205 results were compared.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF12": {
            "text": "-thaw stability was evaluated up to three cycles by freezing and thawing the spiked QC 207 samples stored at -80\u00b0C and comparing the concentrations against the freshly thawed and spiked QC 208 samples.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF13": {
            "text": "Long-term stock solution stability for metabolite stock solutions and intermediate solutions were210 checked by comparing the mean peak area of freshly prepared solutions with stored solutions at 4\u00b0C.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF14": {
            "text": "All stability experiments were performed with six replicates of QCs.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF15": {
            "text": "carry-over was evaluated by injecting the highest standard concentration (ULOQ) of the 214 metabolites in the calibration curve followed by a series of blank injections and lowest standard 215 concentration (LLOQ). The blank samples were evaluated for any signal at the retention time of 216 particular metabolites and signal intensities of the blank samples were compared with the LLOQ 217 samples. The acceptance criteria for carry-over was set at 20% of the peak area corresponding to the 218 LLOQ level as per the EMA guidelines for bioanalysis.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF16": {
            "text": "samples were prepared after separating serum from pooled healthy human 221 blood samples. A volume of 350 \u00b5L of serum was aliquoted and stored at -80 o C after providing a lot 222 number and QC number. The concentration of QC samples that were incorporated in batches during 223 the metabolomics studies were calculated for all the metabolites along with the experimental 224 samples. Average concentrations (\u03bcmol/L) and %CV of the QC samples were calculated for each 225 metabolite. The data were saved along with QC lot numbers, batch name, and run date. The QC data 226were collected from six different lots for a period of 5.5 years (N=539 replicates). An internal QC 227 database has been maintained and used for quality checks.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF17": {
            "text": "evaluate the performance of our semi-quantitative method, commercially available standard 230 reference plasma (NIST SRM 1950) [39] was analyzed using our method (N=8 replicates). The 231 concentration values from the matched 17 metabolites were compared with the given standard 232 reference values.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF18": {
            "text": "resonance (NMR) platform. We sent our internal QC samples to the BIOCRATES Life 239 Sciences AG (Innsbruck, Austria) (N=3 replicates) and to the NMR Metabolomics Laboratory, School 240 of Pharmacy, University of Eastern Finland (Kuopio, Finland) (N=3 replicates). Our QC samples were 241 extracted and analyzed as described previously for the AbsoluteIDQ p180 kit [40] and for the NMR242 analysis of small molecules [41]. We compared these results with the results obtained from estimate the median concentration values (\u03bcmol/L) of the metabolites from QC samples (N=539), 248 we fitted a linear mixed model with the MCMCglmm R package [42] using an expanded parameter 249 formulation and default settings. Observed data was assumed to be log-normally distributed and 250 corrected for the six different QC lots. Credibility intervals (95%) of median concentration values 251 were computed from 20 000 samples of the posterior distribution. Error bars shown in the scatter 252 plots are 95% confidence intervals, while the coefficient of determination R 2 refers to the simple linear 253 regression between the two plotted variables. Coefficient of variation (CV) percentages were 254 calculated as a measure of variability. To automate the downstream processing of the data produced 255 by the instrument vendor software (TargetLynx), we built a data processing package called \"Unlynx\" 256 in R statistical programming language. 257 258 2.5. Automated data processing 259 The \"Unlynx\" package parses the output of TargetLynx software (i.e., raw data containing the 260 concentration values in PPB units) and produces a processed dataset in an Excel spreadsheet after 261 performing a series of preprocessing operations.262The preprocessing steps included the following:263(i) Molecular weight normalization, in which the ppb values are normalized by the molecular 264 weight of each compound, thereby converting the data from ppb units to \u00b5moles.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF19": {
            "text": "298 dental carries, biofilm, extracellular vesicles, mitochondrial isolates, drosophila, C. elegans, E. coli, and 299 S. cerevesiae samples (Illustration of different sample types from various organisms that have been used for extraction 303 method optimization.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF21": {
            "text": "311retention time windows, indicating the selectivity of the metabolites in our method. We repeated the 312 injections for five times from all different serum samples and confirmed that the peak eluted was 313 only from the target analyte, indicating that they are specific to their corresponding MRM transitionsFigureRepresentative chromatographic peaks of selected metabolites at their respective retention times 316 in the QC serum sample.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF23": {
            "text": "Inter-batch variation of high concentrations of spiked QC serum samples (N=6) analyzed on 332 3 different days. Data not shown for g-glutamylcysteine and orotic acid (CV>30%).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF25": {
            "text": "Percentage mean recoveries for all metabolites at low, medium, and high concentration",
            "latex": null,
            "type": "figure"
        },
        "FIGREF26": {
            "text": "360 levels of QCs (N=6 at each level) spiked in serum, brain, spleen, liver, and adherent cells. Data not 361 shown for metabolites with poor chromatography and irreproducible results at different 362 concentration levels. 363 364 author/funder. All rights reserved. No reuse allowed without permission.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF27": {
            "text": "374 intermediate solutions for all the metabolites. Most of the metabolites were stable for 245 days at 375 intermediate concentration when stored at 4 o C. However, 16 metabolites had low stability at 376 intermediate concentration; stabilities were thus determined at stock-level concentration for these 377 compounds. We observed that the stock solutions were stable for 56 days except taurocholic acid,378sucrose, UDP-glucose, and glutamine (Figure 6). Hence, these stock solutions were freshly prepared 379 during the analysis. The stability of internal standards solutions was also assessed and they were 380 stable for one year.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF29": {
            "text": "Percentage mean stability was calculated for three different concentrations (low, medium, 382 and high) spiked in QC serum (N=6 at each level) during (A) wet extract and (B) freeze-thaw stability 383 for all the metabolites.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF31": {
            "text": "Bar graph representing stability of stock solutions and intermediate solutions of metabolites 385 that were used to freshly prepare calibration curve standards during the analysis.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF33": {
            "text": "ensure good quality of the data, internal QC samples were incorporated to a batch of samples 394 and run after every tenth experimental sample. QC data were collected from 25 different batches that 395 were performed during various metabolomics studies over a period of 1 year. Mean concentrations 396 and %CV values of QC replicates within each batch were calculated for all the 25 batches. We397observed that approximately 80% to 85% of the metabolites were always present within 25% of CV 398 values(Figure 7). The higher %CV values for the remaining metabolites could be partially explained 399 by low abundance in human serum, low recovery, or poor chromatography; these were consistently 400 found to be below LLOQ within the 25 batches.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF34": {
            "text": "In addition, %CV values for retention times and R 2 values of calibration curves for each 402 metabolite in all the 25 batches were calculated to verify the reproducibility. Based on these results,403 the repeatability was excellent except for a few compounds over a period of 1 year. No drifting effect 404 for the retention times (CV<4%) was observed, and excellent reproducibility was observed for R 2 405 values of calibration curves (CV<3%) (Figure 8). On the basis of these results, our method can be 406 considered accurate, reliable, and reproducible. Percentage of metabolites with less than 25% CV values of QC concentrations in 25 Reproducibility of (A) retention time of respective chromatographic peaks and (B) regression 414 coefficient values (R 2 ) from external calibration curve standards for each metabolite analyzed in 25 different 415 batches over a period of 1 year.416 author/funder. All rights reserved. No reuse allowed without permission.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF35": {
            "text": "433chromatography peak integrations, IS response variation, and verifying LLOQ and ULOQ for each 434 sample for all metabolites within a batch. The high-throughput targeted metabolomics workflow A typical workflow for high-throughput targeted metabolomics analysis.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF36": {
            "text": "collected concentration values (\u03bcmol/L) for our QC samples within metabolomics studies 442 conducted over a period of 5.5 years from six different lots (N=539 replicates). The median values of 443 each metabolite together with a 95% credibility interval are presented inTable 1. These represent a 444 reference level for a population of healthy adult individuals.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF37": {
            "text": "452 metabolite concentrations analyzed using our method against two completely different analytical 453 platforms (BIOCRATES AbsoluteIDQ p180 kit and NMR) in our QC samples. We obtained a high 454 correlation coefficient for matched 38 metabolites measured using BIOCRATES AbsoluteIDQ p180 455 kit and our method (R 2 =0.975) (Figure 10B) and for matched 22 metabolites measured using NMR 456 and our method (R 2 =0.884) (Figure 10C). These results demonstrate the robustness of our method. (A) Comparison of metabolite concentration reference values given in the NIST SRM 1950 plasma 465 against our method. Comparison of metabolite concentrations in our QC samples measured between our method 466 and (B) BIOCRATES AbsoluteIDQ p180 kit, and (C) NMR analyses.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF38": {
            "text": "the raw data processing using the instrument-coupled software (TargetLynx), a single-471 sheet excel file containing information such as sample ids, file name, and concentrations (PPB) is 472 generated in a complex format for all metabolites. For example, in a single-batch run of 85 samples, 473 after data processing the concentration values for all samples are obtained under each metabolite 474 separately. This means that if a data matrix of 85 samples x 100 metabolites is desired, each individual 475 concentration value must be copied and pasted in another sheet. PPB values are then converted into 476 \u00b5M and corrected for process efficiencies and dilution factors (if any) and normalized with tissue 477",
            "latex": null,
            "type": "figure"
        },
        "FIGREF39": {
            "text": "487 addition, mean concentrations and %CV of QC samples for all the metabolites are calculated and 488 used to evaluate quality by comparing with the in-house QC database constructed based on inter-day 489 %CV. Furthermore, retrieving LLOQ, ULOQ, and outlier values in each phenotypic group according 490 to one and two standard deviations, retention time values, and R 2 values for each metabolite is 491implemented in the R software. After implementing the automated data processing, we had reduced 492 the 2-day manual workload to a few minutes.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF40": {
            "text": "Contributions: J.N. performed all the validation experiments, processed the data, and wrote the 531 manuscript. M.K. and J.N. were involved in extraction protocol optimization. G.P. developed the R package 532 (Unlynx) for automated data processing. A.P. performed the QC data analysis, prepared the related table, and 533 wrote the corresponding section. V.V. conceived, designed, and supervised the study, and wrote and edited the 534 manuscript. All authors edited the manuscript.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF41": {
            "text": "Conflicts of Interest:The authors declare no conflict of interest. The sponsors had no role in the design of the 536 study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; and in the decision 537 to publish the results.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF43": {
            "text": ", K.; Aronov, P.A.; Hammock, B.D. Mass spectrometry-based metabolomics. Mass Spectrom Rev.551 2007, 26, 51-78, DOI:10.1002/mas.20108.552 6. Abdel Rahman, A.M.; Pawling, J.; Ryczko, M.; Caudy, A.A.; Dennis, J.W. Targeted metabolomics in 553 cultured cells and tissues by mass spectrometry: Method development and validation. Anal Chim Acta. 554 2014, 845, 53-61, DOI:10.1016/j.aca.2014.06.012. 555 7. Villas-B\u00f4as, S.G.; Mas, S.; \u00c5kesson, M.; Smedsgaard, J.; Nielsen, J. Mass spectrometry in metabolome 556 analysis. Mass Spectrom Rev. 2005, 24, 613-646, DOI:10.1002/mas.20032. 557 8. Virgiliou, C.; Sampsonidis, I.; Gika, H.G.; Raikos, N.; Theodoridis, G.A. Development and validation of 558 a hilic-ms/ms multitargeted method for metabolomics applications. Electrophoresis 2015, 36, 2215-2225, 559 DOI:10.1002/elps.201500208.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF44": {
            "text": ", J.; Chen, Y.-T.; Chen, C.-L.; Li, L. Development of a universal metabolome-standard method for 561 long-term lc-ms metabolome profiling and its application for bladder cancer urine-metabolite-562 biomarker discovery. Anal Chem. 2014, 86, 6540-6547, DOI:10.1021/ac5011684.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF45": {
            "text": "N.A.; Auranen, M.; Paetau, I.; Pirinen, E.; Euro, L.; Forsstr\u00f6m, S.; Pasila, L.; Velagapudi, V.; 564 Carroll, C.J.; Auwerx, J.; Suomalainen, A. Effective treatment of mitochondrial myopathy by 565 nicotinamide riboside, a vitamin B3. EMBO Mol Med. 2014, 6, 721, DOI:10.1002/emmm.201403943.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF46": {
            "text": "Roman-Garcia, P.; Quiros-Gonzalez, I.; Mottram, L.; Lieben, L.; Sharan, K.; Wangwiwatsin, A.; Tubio, 567 J.; Lewis, K.; Wilkinson, D.; Santhanam, B.; Sarper, N.; Clare, S.; Vassiliou, G.S.; Velagapudi, 568 V.R.; Dougan, G.; Yadav, V.K. Vitamin b12-dependent taurine synthesis regulates growth and bone 569 mass. J Clin Invest. 2014, 124, 2988-3002, DOI:10.1172/JCI72606.570 author/funder. All rights reserved. No reuse allowed without permission.",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "were provided by our research collaborators. NIST Standard reference material (SRM) 1950 plasma 144 was purchased from Sigma-Aldrich (Gillingham, UK).All metabolites were extracted, separated with HILIC chromatography (Acquity BEH amide, 2.1 148 X 100 mm, 1.7\u00b5), and analyzed with a Waters Xevo TQ-S mass spectrometer using our previously 149 published protocol[11]. The protocol for tissues and adherent cells was optimized for better recovery 150 and chromatography and to cover a wide range of tissue and cell types with a single protocol. For 151 tissue sample extractions, 90/10% ACN/H2O + 1% formic acid was used instead of 80/20% ACN/H2O 152 + 1% formic acid during the second step of extraction. Additionally, during cell pellet sample 153 extraction, 80/20% ACN/H2O+1% formic acid was replaced with 90/10% ACN/H2O + 1% formic acid.",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "The cell pellet protocol was used for all types of adherent cells and E. coli 157 and S. cerevisiae samples. The biofluid protocol was used for all types of biofluids, such as blood, plasma, serum, cell culture supernatant, CSF, and urine. Validation of the method was performed to verify various parameters and the reliability of the 162 developed method for analysis of a large number of samples. The method was validated according 163 to EMA guidelines for bioanalytical method validation in terms of selectivity, specificity, linearity, 164 accuracy, precision, extraction recovery, matrix effect, and stability [38]. In addition, we used pooled 165 healthy human serum samples as internal quality control (QC) samples in all studies to correct signal 166 drift during sample runs and to improve confidence in the statistical data. QC samples at high,",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "database of QC sample RSDs (based on inter-day RSDs recorded over one year).",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101There were no significant interference peaks from the matrix components in their respective",
            "latex": null,
            "type": "table"
        },
        "TABREF4": {
            "text": "Endogenous metabolites are not stable due to degradation or conversion reactions. Hence, the stabilities of all metabolites were assessed under different conditions. For wet extract stability,",
            "latex": null,
            "type": "table"
        },
        "TABREF5": {
            "text": "Median concentration levels (\u03bcmol/L) measured in pooled healthy adult serum samples.",
            "latex": null,
            "type": "table"
        },
        "TABREF6": {
            "text": "such as statistical 496 hypotheses testing, classification, regression, and clustering) aimed at answering specific scientific 497 questions related to the study design. Applicability of the method We have applied our fully validated analytical methodology in various international and national 501 biomedical research projects, epidemiological studies, clinical studies including dietary 502 interventions, and clinical trials. We have successfully implemented our technology in the following 503 research fields, including but not limited to: mitochondrial metabolism/disorders [11,17-23], cancer 504 [24,25], bone metabolism [12], endocrinology [26,27], psychiatric disorders [28], inflammatory bowel disease [29], viral infections [30-33], allergies [34,35], circadian rhythms [36], and pain research [37].",
            "latex": null,
            "type": "table"
        },
        "TABREF7": {
            "text": "List of metabolites showing molecular weight, retention time, linearity of calibration, and compound dependent MS parameters.author/funder. All rights reserved. No reuse allowed without permission.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/352468 doi: bioRxiv preprint Acknowledgments: The authors would like to thank all the collaborators, especially Prof. Anu Wartiovaara for providing the biological samples; Jean-Christophe Yorke, Vasudev Kantae, Kenneth Nazir, and Bharat Gajera for technical assistance, and Dr. Janne Wallenius for reviewing the manuscript. The Biocenter Finland and HiLIFE supported this work.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}